bannerWeb
PROGRAM

  • 09:30-13:30 LOCAL PROGRAM. CARDIO 1, 2, 3 PLUS. ADVANCED MEDICAL SIMULATION WORKSHOPS!
    Coordinator: José María García Acuña

    Simultaneous workshops:
    • ECMO
      Room Castelao
      Marta Ruiz (Santander, Spain)
      Virginia Burgos (Santander, Spain)
      Sergio Santos (Santander, Spain)
      Inmaculada García-Montesinos (Santander, Spain)
    • Pulmonary echography
      Room Anatomía
      Albert Duran (Barcelona, Spain)
      Wlalter Bragagni (Barcelona, Spain)
    • Advanced Cardio-pulmonary resuscitation
      Room Habilidades
      Lucia Rioboo (Vigo, Spain)
      Cristina González-Cambeiro (Pontevedra, Spain)
      Antonela Lukic (Zaragoza, Spain)
      Montserrat Vila (Barcelona, Spain)
    • Central iv lines
      Room 1
      Jordi Bañeras (Barcelona, Spain)
    14:00-15:00 Lunch
    15:00-16:00 CONTROVERSY FROM BOTH SIDES OF ATLANTIC: “CLINICAL TRIALS: LIGHTS AND SHADOWS”
    Chairs: Héctor Bueno and Antonio Fernández-Ortiz
    • "Lessons from a Trialist: A Critique of some recent Cardiology Trials"
      Stuart Pocock (London, UK)
    • "Perspectives on trials of coronary revascularization for stable CAD".
      Bernard Gersch (Rochester, USA)
    16:00-17:00 UPDATE I
    “Update in management of anticoagulant therapy in patients with Atrial Fibrillation”
    Chairs: Inmaculada Roldán and José Luis Ferreiro

    Speakers:
    • Questions and answers about combination of antiplatelet and anticoagulant therapy in patients with ischemic heart disease.
      Dominick Angiolillo (Jacksonville, USA)
    • Perioperative and periprocedural management of anticoagulant therapy.
      David Vivas (Madrid, Spain)
    • Spanish results of the GARFIELD registry.
      Xavier Viñolas (Barcelona, Spain)
    17:00-17:30 Coffee break
    17:30-18:30 UPDATE II
    DIABETES AND ISCHAEMIC HEART DISEASE IN 2018: IT’S TIME FOR CARDIOOGIST TO GIVE A STEP FORWARD
    Chair: José R. González Juanatey
    • How I do It? Revascularization in diabetics with acute coronary syndromes and multivessel disease.
      Belen Cid (Santiago de Compostela, Spain)
    • Selection of antithrombotic treatment and secondary prevention.
      Alfredo Bardaji (Tarragona, Spain)
    • Cardiovascular safety of oral antidiabetic therapy. Current reccomendations in diabetics with ischaemic heart disease.
      José R. González Juanatey (Santiago de Compostela, Spain)
    • Acute coronary syndromes in diabetic patients. The case for continuity of care.
      Almudena Castro (Madrid, Spain)
    18:30-19:30 “MAGDA HERAS” LECTURE. OPENING CONFERENCE
    Chairs: Alessandro Sionis and Rosa-Maria Lidón

    “Innovative approaches to the future management of CHF”.
    Bernard Gersh (Rochester, USA)
    19:30-20:00 OPENING CEREMONY
  • 08:30-10:00 THE 2017 ESC GUIDELINES: A BACKSTAGE LOOK
    Chairs: Borja Ibáñez and Héctor Bueno
    • STEMI.
      Borja Ibáñez (Madrid, Spain)
    • DAPT.
      Francesco Costa (Milan, Italy)
    • Valve Disease.
      Pilar Tornos (Barcelona, Spain)
    10:00-10:45 CURRENT CHALLENGES IN ACUTE ENDOCARDITIS MANAGEMENT: DIALOGUE WITH THE EXPERTS
    Chairs: Alberto San Román and Alberto Forteza

    Speakers:
    Pilar Tornos (Barcelona, Spain)
    Eduard Quintana
    (Barcelona, Spain)
    10:45-11:15 Coffee break
    11:15-12:15 COMPLEX SCENARIOS IN CORONARY REVASCULARIZATION
    Chairs: José M. de la Torre Hernández and Jaime Aboal
    • “Revascularization in stable CAD: waiting for the ultimate trial ".
      Adnan Kastrati (Munich, Germany)
    • “How to individualize DAPT duration after PCI in ACS: the PRECISE DAPT score”.
      Francesco Costa (Milan, Italy)
    • “Revascularization in patients with STEMI and multivessel disease”.
      Adnan Kastrati (Munich, Germany)
    12:15-13:15 UPDATE III
    Atherosclerosis a global pathology: Raiders of the lost treatment
    Chair: Rosa- Maria Lidón
    • Prescribed therapy in real world
      Alberto Cordero (Alicante, Spain)
    • How to improve therapeutic adherence in the patient with stroke
      Jaime Masjuna (Madrid, Spain)
    • In ischemic heart disease patients, what does the polypill give us?
      Antonio Fernández Ortiz (Madrid, Spain)
    13:30-14:30 Lunch
    LUNCH WITH THE LEGENDS (ahead booking required)
    Hotel Monumento San Francisco
    • Table 1: Susanna Price (London, UK) and Héctor Bueno (Madrid, Spain)
    • Table 2: Adnan Kastrati (Munich, Germany) and Antonio Fernández-Ortíz (Madrid, Spain)
    • Table 3: Alex Mebazaa (Paris, France) and José Ramón González Juanatey (Santiago de Compostela, Spain)
    • Table 4: Bernard Gersh (Rochester, USA) and Esteban López de Sa (Madrid, Spain)
    14:30-16:00 FOCUS ON CARDIOGENIC SHOCK
    Chairs: Alessandro Sionis and Roberto Martín Asenjo
    • Multiorgan failure in cardiogenic shock.
      Alex Mebazaa (Paris, France)
    • Coronary revascularization.
      Uwe Zeymer Ludwigshafen am Rhein, (Germany)
    • VADs: tell us when, which and how.
      Susanna Price (London, UK)
    16:00-17:00 UPDATE IV
    Interactive debate with the experts: New evidence in dyslipidemia treatment

    Chair:
    New evidence in dyslipidemia treatment
    José Ramón González-Juanatey

    Experts panel:
    José Tuñón (Madrid, Spain)
    Lluís Masana (Tarragona, Spain)
    José Luis López Sendón
    (Madrid, Spain)
    • In which patients should we use a PCSK9i?
    • PCSK9i: always after ezetimibe?
    • LDL-c control: the earlier the better?
    17:00-17:30 Coffee break
    17:30-18:30 NEW INSIGHTS IN ACUTE AORTIC SYNDROMES
    Chairs: Alberto Forteza and Rosa-Maria Lidón
    • The 10 main lessons from 20-year of clinical collaborative research (IRAD and RESA registries).
      Arturo Evangelista (Barcelona, Spain)
    • How can we optimize surgical treatment results in type A AAS?
      Martin Grabenwöger (Vienna, Austria)
    • When medical treatment is not enough in type B acute aortic syndrome?
      Christophe Nienaber (London, UK)
    18:30-20:00 SECONDARY PREVENTION AND MANAGEMENT IN STABLE CORONARY ARTERY DISEASE
    Chairs: José Ramón González Juanatey and Esteban López de Sa
    • What is residual risk and what can I do to reduce it?
      Joao Morais (Leiria, Portugal)
    • Stable coronary artery disease 2018: current role of medical treatment and revascularistation.
      José Luis López Sendón (Madrid, Spain)
    • Dyslipidemia.
      Antonio J. Vallejo-Vaz (London, UK)
    • Diabetes and ischemic heart disease. Challenges in 2018.
      Aldo Pietro Maggioni (Milan, Italy)
  • 09:00-10:00 ROUND TABLE ON ANTITHROMBOTIC TREATMENT
    Chairs: Inmaculada Roldán and José Luis Ferreiro
    • Individualizing duration of dual antiplatelet therapy in ACS patients undergoing coronary stenting: a practical approach beyond the scores.
      Giuseppe Biondi-Zoccai (Roma, Italy)
    • Management of antithrombotic therapy in acute coronary syndrome patients with atrial fibrillation undergoing percutaneous coronary intervention.
      Felicita Andreotti (Roma, Italy)
    • New antithrombotic strategies in ACS: de-escalation of P2Y12 inhibitors, dual therapy with rivaroxaban, ticagrelor monotherapy.
      Dominick Angiolillo (Jacksonville, USA)
    10:00-11:00 UPDATE V
    Discussion Table:
    CardioFighters : Key questions in secondary prevention, hypercholesterolemia and ischemic heart disease.
    Referee:
    Almudena Castro (Madrid, Spain)

    CardioFighters:
    Juan Cosín Sales (Valencia, Spain)
    Carlos Escobar Cervantes (Madrid, Spain)
    11:00-11:30 Coffee break
    11:30-12:30 BIOMARKERS: 25 years of troponin
    Chairs: Josep Masip and Jordi Ordoñez
    • "Biomarkers and coronary syndromes. A long and fruitful relationship".
      Jordi Ordoñez (Barcelona, Spain)
    • “Evolution in the diagnosis of the acute coronary syndrome”.
      Nick Mills (Edinburgh, Scothland)
    • “High-sensitivity cardiac troponins as biomarkers of stable cardiac ischemic disease”.
      Christian Mueller (Basel, Switzerland)
    12:30.13:30 “CASE WARS”: CARDIOLOGY TRAINEES PRESENT THEIR MOST CHALLENGING CLINICAL CASES.
    Chairs: Ivan Nuñez and José Barrabés
    • Cardiogenic shock after STEMI due to embolia. Role of mechanical circulatory support.
      Inés Toranzo (Santander, Spain)
    • Cardiac arrest: When therapeutic hypothermia reveals the mechanism
      Maria Isabel Barrionuevo (Albacete, España)
    Discussants:
    Nick Mills (Edinburgh, Scothland)
    Joao Morais (Leiria, Portugal)
    Christian Mueller (Basel, Switzerland)
    13:30 CLOSING CEREMONY
GRUPO PACIFICO
SECRETARÍA TÉCNICA
Maria Cubi, 4 - Pral.
08006 Barcelona (SPAIN)
Tel. +34 932.388.777
Fax. +34 932.387.488
This email address is being protected from spambots. You need JavaScript enabled to view it.
vueling en